Scientists on effectiveness of vaccines Pfizer and Moderna against “Oomikron”

Booster vaccines vaccine vaccine Pfizer-Biontech and Moderna have demonstrated high efficiency in preventing hospitalization of patients with “Omicron”, evidence data from the Center for the Control and Prevention of Disease Diseases (CDC).

Additional vaccination can reduce the risk of hospitalization by 90%, and the risk of accessing emergency assistance – by 82%, found out scientists.

“This explicitly shows the importance of obtaining a booster dose,” Emma Accisty from CDC, one of the authors of the study.

According to experts, the option of coronavirus “Omicron” extends much faster than previous mutations, however, it represents a slightly smaller hazard of severe disease.